Zobrazeno 1 - 6 of 6 pro vyhledávání: '"MESH: Hepacivirus*/drug effects"'
1
Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation
Autor: Marc Hazzan, Sébastien Dharancy, Christophe Legendre, Hélène Fontaine, Alain Duhamel, Nassim Kamar, Benjamin Legendre, Stanislas Pol, Corinne Antoine, Philippe Mathurin, Alexandre Louvet, Laurent Alric, Julien Labreuche
Publikováno v: Journal of Hepatology
Journal of Hepatology, 2019, 70 (5), pp.831-838. ⟨10.1016/j.jhep.2018.12.036⟩
Journal of Hepatology, Elsevier, 2019, 70 (5), pp.831-838. ⟨10.1016/j.jhep.2018.12.036⟩
International audience; Background & aims: Before antiviral therapy, kidney transplant recipients infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) had poor outcomes. Since the 90s, nucleos(t)ide analogues have been widely used in HBV-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e4f9e412772509fd90466e2df10fb88
https://doi.org/10.1016/j.jhep.2018.12.036
Zobrazit plný text záznamu
2
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Autor: Matthew L. Albert, Yoann Barthe, Armanda Casrouge, Arnaud Fontanet, Stanislas Pol, Sylvie Lagaye, Hélène Fontaine, Vincent Mallet, Philippe Sultanik, Christophe Hézode, Estelle Mottez, Laurent Abel, Etienne Gayat, Céline Dorival, Fabrice Carrat, Jean-Pierre Bronowicki, Ioannis Theodorou
Publikováno v: Liver International
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. 〈10.1111/liv.12759〉
International audience; BACKGROUND & AIMS:Chronic infection with HCV remains a public health problem with approximately 150 million people infected worldwide. HCV intersects with lipid metabolism for replication and entry; and plasma concentrations o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90633f842d8de6ea3f7f4df0ad3c882d
https://doi.org/10.1111/liv.12759
Zobrazit plný text záznamu
3
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy
Autor: Darragh Duffy, Eric G. Meissner, Henry Masur, Shyam Kottilil, Matthew L. Albert, Jérémie Decalf, Armanda Casrouge
Publikováno v: PLoS ONE
PLoS ONE, 2015, 10 (7), pp.e0133236. ⟨10.1371/journal.pone.0133236⟩
PLoS ONE, Vol 10, Iss 7, p e0133236 (2015)
PLoS ONE, Public Library of Science, 2015, 10 (7), pp.e0133236. ⟨10.1371/journal.pone.0133236⟩
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy. Elevated levels of NH2-terminal truncated CXCL10 (3-77aa), produced by DPP4 cleavage, negativ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34288c84d102b5e0fb82496371553986
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380964/file/journal.pone.0133236.PDF
Zobrazit plný text záznamu
4
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection
Autor: Vincent Mallet, Christophe Hézode, Rasha Mamdouh, Mona Rafik, Alexandre Soulier, Isabelle Rosa, Amira Mohsen, Mai El-Daly, Lenaig Le-Fouler, Philippe Renard, Jacques Izopet, Philippe Bonnard, Melissa E. Laird, Armanda Casrouge, Arnaud Fontanet, Stanislas Pol, Mostafa K. Mohamed, Darragh Duffy, Jean-Michel Pawlotsky, Matthew L. Albert, Mohamed Abdel-Hamid
Publikováno v: Journal of Hepatology
Journal of Hepatology, Elsevier, 2014, 61 (4), pp.770-776. ⟨10.1016/j.jhep.2014.05.040⟩
Journal of Hepatology; Vol 61
Journal of Hepatology, 2014, 61 (4), pp.770-776. ⟨10.1016/j.jhep.2014.05.040⟩
International audience; BACKGROUND & AIMS:HCV requires host lipid metabolism for replication, and apolipoproteins have been implicated in the response to treatment.METHODS:We examined plasma apolipoprotein concentrations in three cohorts of patients:
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65e22babc37f616ddcec22f8adee8ac
https://hal-pasteur.archives-ouvertes.fr/pasteur-01384212
Zobrazit plný text záznamu
5
Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system
Autor: Gilles Duverlie, Czeslaw Wychowski, Virginie Zurawski, Ngoc Vu-Dac, Muriel Lavie, Cécile Voisset, Jean Dubuisson
Publikováno v: Hepatology
Hepatology, Wiley-Blackwell, 2006, 44, pp.1626-1634. ⟨10.1002/hep.21406⟩
International audience; Serum amyloid A (SAA) is an acute phase protein produced by the liver. SAA concentration increases markedly in the serum following inflammation and infection. Large increases in SAA concentration during the acute phase respons
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16b7fd3ee213c6b84e782a3e3c14762f
https://hal.archives-ouvertes.fr/hal-00183312
Zobrazit plný text záznamu
6
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles
Autor: Christian Trepo, Nicole Zitzmann, Raymond A. Dwek, C Chapel, Fabien Zoulim, Philippe Roingeard, Jean Dubuisson, David Durantel, C Garcia
Publikováno v: Journal of General Virology
Journal of General Virology, Microbiology Society, 2006, 87, pp.861-871. ⟨10.1099/vir.0.81503-0⟩
Hepatitis C virus (HCV) infections are a major public-health concern. New antiviral drugs are needed urgently to complement and improve the efficacy of current chemotherapies. The morphogenesis of HCV represents an interesting, and still unexploited,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8bfdeb5ee4b726800c187bb52ad37ce
http://ora.ox.ac.uk/objects/uuid:8e47963b-28b4-4712-8d4a-4607d03d258d
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje